Don't Miss our Black Friday Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
GoHealth (GOCO) has provided an update.
Joseph G. Flanagan has announced his resignation from the GoHealth, Inc. Board of Directors, effective June 25, 2024. During his tenure, Flanagan held key roles including Chairperson of the Nominating and Corporate Governance Committee and lead independent director. His departure is amicable, with no disputes over company operations, policies, or practices. Alexander Timm is set to take over as the new lead independent director.
Find detailed analytics on GOCO stock on TipRanks’ Stock Analysis page.
